Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Platelet aggregation in arterial hypertension]

R Hernández Hernández1, A R Carvajal, M J Armas de Hernández

  • 1Unidad de Farmacología Clínica, Decanato de Medicina, Universidad Centroccidental Lisandro Alvarado, Barquisimeto, Edo. Lara, Venezuela.

Investigacion Clinica
|February 21, 1998
PubMed
Summary

Hypertension causes platelet hyper-aggregation, increasing stroke and heart attack risks. Certain blood pressure medications help restore the balance of pro- and anti-aggregating factors, improving cardiovascular health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011.

Cerebrovascular diseases (Basel, Switzerland)·2012
Same author

Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006.

Cerebrovascular diseases (Basel, Switzerland)·2006
Same author

Mannheim intima-media thickness consensus.

Cerebrovascular diseases (Basel, Switzerland)·2004
Same author

A system of complementary genes in hybrids between Drosophila koepferae and D. buzzatii: a Markov chain model allows to make inferences about their number and relationships.

Genes & genetic systems·2002
Same author

Effect of lacidipine and nifedipine GITS on platelet function in patients with essential hypertension.

Journal of human hypertension·2000
Same author

Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension.

International journal of clinical pharmacology and therapeutics·1999

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Pharmacology

Context:

  • Hypertension is a primary risk factor for cardiovascular events like stroke and myocardial infarction.
  • Platelets are crucial in atherogenic processes and cardiovascular disease development.
  • Physiological hemostasis involves a balance between pro- and anti-aggregating factors, which is disrupted in hypertension.

Purpose:

  • To investigate the role of platelet aggregation in hypertension-related cardiovascular risks.
  • To explore the impact of hypertension on eicosanoid production and platelet function.
  • To evaluate how antihypertensive drugs affect platelet aggregation and eicosanoid balance.

Summary:

  • Patients with hypertension exhibit hyper-aggregation and an imbalanced production of eicosanoids, disrupting the normal equilibrium of platelet function.

Related Experiment Videos

  • This imbalance favors pro-aggregating factors, contributing to the atherogenic process and increasing the risk of thrombotic events.
  • Antihypertensive medications can not only lower blood pressure but also mitigate platelet hyper-aggregation and restore eicosanoid equilibrium.

    • Impact:

    • Understanding the link between hypertension, platelet function, and eicosanoids can lead to improved therapeutic strategies.
    • Antihypertensive drugs may offer dual benefits by controlling blood pressure and reducing thrombotic risk.
    • This research highlights the importance of considering platelet activity in managing hypertensive patients to prevent cardiovascular complications.